Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Obstet Gynecol ; 142(6): 1333-1340, 2023 Dec 01.
Artigo em Inglês | MEDLINE | ID: mdl-37917941

RESUMO

Preeclampsia is associated with significant perinatal morbidity and mortality. Aspirin has been long purported and extensively studied for prevention of preeclampsia. For this reason, the U.S. Preventive Services Task Force, the American College of Obstetricians and Gynecologists, and the Society for Maternal-Fetal Medicine recommend its use in pregnancy for preeclampsia prevention in those at high risk. Yet, much controversy exists regarding optimal use in pregnancy with guidelines across global organizations varying. In this narrative review, we summarize the published literature related to the safety, optimal dose, and timing and duration of use of aspirin, as well as other indications for which aspirin has been studied in pregnancy.


Assuntos
Aspirina , Pré-Eclâmpsia , Gravidez , Feminino , Humanos , Aspirina/efeitos adversos , Pré-Eclâmpsia/tratamento farmacológico , Inibidores da Agregação Plaquetária/efeitos adversos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA